Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Post

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
International Journal of Molecular Sciences|August 29, 2024
AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of GlaucomaSophia Millington-Ward, Arpad Palfi, Ciara Shortall, et al.
Clinical and Translational Medicine|August 21, 2022
AAV-mediated gene therapy improving mitochondrial function provides benefit in age-related macular degeneration modelsSophia Millington-Ward, Naomi Chadderton, Laura K Finnegan, et al.
Journal of Autoimmunity|November 16, 2024
Trained innate immunity in response to nuclear antigens in systemic lupus erythematosusCansu Yanginlar, Nils Rother, Tomas G J M Post, et al.
Scientific Reports|June 9, 2023
Detailed analysis of an enriched deep intronic ABCA4 variant in Irish Stargardt disease patientsLaura Whelan, Adrian Dockery, Kirk A J Stephenson, et al.
Journal of Medicinal Chemistry|September 11, 1998
Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme factor XaG B Phillips, B O Buckman, D D Davey, et al.
Elife|September 20, 2022
FSH-blocking therapeutic for osteoporosisSakshi Gera, Tan-Chun Kuo, Anisa Azatovna Gumerova, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
International Journal of Molecular Sciences|August 29, 2024
AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of GlaucomaSophia Millington-Ward, Arpad Palfi, Ciara Shortall, et al.
Clinical and Translational Medicine|August 21, 2022
AAV-mediated gene therapy improving mitochondrial function provides benefit in age-related macular degeneration modelsSophia Millington-Ward, Naomi Chadderton, Laura K Finnegan, et al.
Journal of Autoimmunity|November 16, 2024
Trained innate immunity in response to nuclear antigens in systemic lupus erythematosusCansu Yanginlar, Nils Rother, Tomas G J M Post, et al.
Scientific Reports|June 9, 2023
Detailed analysis of an enriched deep intronic ABCA4 variant in Irish Stargardt disease patientsLaura Whelan, Adrian Dockery, Kirk A J Stephenson, et al.
Journal of Medicinal Chemistry|September 11, 1998
Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme factor XaG B Phillips, B O Buckman, D D Davey, et al.
Elife|September 20, 2022
FSH-blocking therapeutic for osteoporosisSakshi Gera, Tan-Chun Kuo, Anisa Azatovna Gumerova, et al.
Pageof 3